NO996264D0 - Behandling av diabetes med tiazolidindion og sulfonylurea - Google Patents

Behandling av diabetes med tiazolidindion og sulfonylurea

Info

Publication number
NO996264D0
NO996264D0 NO996264A NO996264A NO996264D0 NO 996264 D0 NO996264 D0 NO 996264D0 NO 996264 A NO996264 A NO 996264A NO 996264 A NO996264 A NO 996264A NO 996264 D0 NO996264 D0 NO 996264D0
Authority
NO
Norway
Prior art keywords
thiazolidinedione
sulfonylurea
diabetes
treatment
Prior art date
Application number
NO996264A
Other languages
English (en)
Other versions
NO326263B1 (no
NO996264L (no
Inventor
Stephen Alistair Smith
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26311744&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO996264(D0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from GBGB9712854.0A external-priority patent/GB9712854D0/en
Priority claimed from GBGB9806710.1A external-priority patent/GB9806710D0/en
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Publication of NO996264D0 publication Critical patent/NO996264D0/no
Publication of NO996264L publication Critical patent/NO996264L/no
Publication of NO326263B1 publication Critical patent/NO326263B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/145—Amines having sulfur, e.g. thiurams (>N—C(S)—S—C(S)—N< and >N—C(S)—S—S—C(S)—N<), Sulfinylamines (—N=SO), Sulfonylamines (—N=SO2)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/426—1,3-Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/427—Thiazoles not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/64—Sulfonylureas, e.g. glibenclamide, tolbutamide, chlorpropamide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
    • A61P5/50—Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Obesity (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Emergency Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
NO19996264A 1997-06-18 1999-12-17 Kombinasjon omfattende tiazolidindion og sulfonylurea, anvendelse derav, samt farmasoytisk sammensetning NO326263B1 (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB9712854.0A GB9712854D0 (en) 1997-06-18 1997-06-18 Novel method of treatment
GBGB9806710.1A GB9806710D0 (en) 1998-03-27 1998-03-27 Novel method
PCT/EP1998/003688 WO1998057649A1 (en) 1997-06-18 1998-06-15 Treatment of diabetes with thiazolidinedione and sulphonylurea

Publications (3)

Publication Number Publication Date
NO996264D0 true NO996264D0 (no) 1999-12-17
NO996264L NO996264L (no) 2000-02-17
NO326263B1 NO326263B1 (no) 2008-10-27

Family

ID=26311744

Family Applications (3)

Application Number Title Priority Date Filing Date
NO19996264A NO326263B1 (no) 1997-06-18 1999-12-17 Kombinasjon omfattende tiazolidindion og sulfonylurea, anvendelse derav, samt farmasoytisk sammensetning
NO20083276A NO20083276L (no) 1997-06-18 2008-07-24 Behandling av diabetes med tiazolidindion og sulfonylurea
NO2009002C NO2009002I1 (no) 1997-06-18 2009-02-13 5-{4-[2-(N-metyl-N-(2-pyridyl)amino)etoksy]benzyl}tiazolidin-2,4-dionmaleat(salter/solvater)+glimepirid

Family Applications After (2)

Application Number Title Priority Date Filing Date
NO20083276A NO20083276L (no) 1997-06-18 2008-07-24 Behandling av diabetes med tiazolidindion og sulfonylurea
NO2009002C NO2009002I1 (no) 1997-06-18 2009-02-13 5-{4-[2-(N-metyl-N-(2-pyridyl)amino)etoksy]benzyl}tiazolidin-2,4-dionmaleat(salter/solvater)+glimepirid

Country Status (34)

Country Link
EP (3) EP0999845B1 (no)
JP (1) JP2001523270A (no)
KR (3) KR20010013840A (no)
CN (1) CN1168451C (no)
AP (1) AP1600A (no)
AR (2) AR008025A1 (no)
AT (1) ATE353654T1 (no)
AU (1) AU8539298A (no)
BG (2) BG109397A (no)
BR (1) BR9810142A (no)
CA (1) CA2294385C (no)
CO (1) CO4940457A1 (no)
CZ (1) CZ299310B6 (no)
DE (1) DE69837089T2 (no)
DZ (1) DZ2522A1 (no)
EA (1) EA003025B1 (no)
ES (1) ES2283064T3 (no)
HK (1) HK1028200A1 (no)
ID (1) ID24065A (no)
IL (1) IL133137A (no)
IN (1) IN189319B (no)
MA (1) MA24571A1 (no)
MY (1) MY125855A (no)
NO (3) NO326263B1 (no)
NZ (1) NZ501163A (no)
OA (1) OA11510A (no)
PE (1) PE108199A1 (no)
PL (2) PL337510A1 (no)
SK (1) SK286028B6 (no)
TR (1) TR199903096T2 (no)
TW (1) TW542717B (no)
UA (1) UA67743C2 (no)
UY (1) UY25048A1 (no)
WO (1) WO1998057649A1 (no)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9715295D0 (en) * 1997-07-18 1997-09-24 Smithkline Beecham Plc Novel method of treatment
OA11871A (en) 1999-04-23 2006-03-27 Smithkline Beecham Plc Novel pharmaceutical.
EP1227818A2 (en) * 1999-11-01 2002-08-07 Wisconsin Alumni Research Foundation Abc1 modulation for the modulation of cholesterol transport
WO2002055009A1 (en) 2001-01-12 2002-07-18 Sun Pharmaceutical Industries Limited Spaced drug delivery system
KR100698595B1 (ko) * 2003-09-29 2007-03-21 보령제약 주식회사 무정형 또는 준결정형 글리메피리드, 이의 제조방법 및 무정형 또는 준결정형 글리메피리드를 포함하는 약학적조성물
TWI339586B (en) 2003-10-31 2011-04-01 Takeda Chemical Industries Ltd Solid preparation comprising pioglitazone or salt thereof,glimpiride and polyoxyethylene sorbitan fatty acid ester
BRPI0620020A2 (pt) 2005-12-22 2011-10-25 Takeda Pharmaceutical preparação sólida, e, partìcula revestida
CN104158867B (zh) * 2014-08-06 2017-05-17 电子科技大学 一种基于wave协议的信息多跳转发方法

Family Cites Families (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5522636A (en) 1978-08-04 1980-02-18 Takeda Chem Ind Ltd Thiazoliding derivative
JPS5697277A (en) 1980-01-07 1981-08-05 Takeda Chem Ind Ltd Thiazolidine derivative
JPS6051189A (ja) 1983-08-30 1985-03-22 Sankyo Co Ltd チアゾリジン誘導体およびその製造法
US4582839A (en) 1984-03-21 1986-04-15 Takeda Chemical Industries, Ltd. 2,4-thiazolidinediones
CN1003445B (zh) 1984-10-03 1989-03-01 武田药品工业株式会社 噻唑烷二酮衍生物，其制备方法和用途
DK173350B1 (da) 1985-02-26 2000-08-07 Sankyo Co Thiazolidinderivater, deres fremstilling og farmaceutisk paæparat indeholdende dem
JPH06779B2 (ja) 1985-06-10 1994-01-05 武田薬品工業株式会社 チアゾリジオン誘導体およびそれを含んでなる医薬組成物
US4812570A (en) 1986-07-24 1989-03-14 Takeda Chemical Industries, Ltd. Method for producing thiazolidinedione derivatives
EP0842925A1 (en) * 1987-09-04 1998-05-20 Beecham Group Plc Substituted thiazolidinedione derivatives
US4791125A (en) 1987-12-02 1988-12-13 Pfizer Inc. Thiazolidinediones as hypoglycemic and anti-atherosclerosis agents
WO1989008650A1 (en) 1988-03-08 1989-09-21 Pfizer Inc. Thiazolidinedione hypoglycemic agents
WO1989008651A1 (en) 1988-03-08 1989-09-21 Pfizer Inc. Hypoglycemic thiazolidinedione derivatives
WO1991007107A1 (en) 1989-11-13 1991-05-30 Pfizer Inc. Oxazolidinedione hypoglycemic agents
US5089514A (en) 1990-06-14 1992-02-18 Pfizer Inc. 3-coxazolyl [phenyl, chromanyl or benzofuranyl]-2-hydroxypropionic acid derivatives and analogs as hypoglycemic agents
HUT65619A (en) 1990-07-03 1994-07-28 Yamanouchi Pharma Co Ltd Process for producing bisheterocyclic compounds and pharmaceutical preparations containing them
KR930701420A (ko) 1990-08-23 1993-06-11 알렌 제이. 스피겔 혈당저하제로서의 하이드록시우레아 유도체
JPH04210683A (ja) 1990-12-06 1992-07-31 Terumo Corp チアゾリジン−２，４−ジオン誘導体およびこれを含有する糖尿病合併症治療薬
US5183823A (en) 1991-04-11 1993-02-02 Takeda Chemical Industries, Ltd. Pyridine n-oxide compounds which are useful as hypoglycemic and hypolipidemic agents
ES2161692T3 (es) 1991-04-11 2001-12-16 Upjohn Co Derivados de tiazolidindiona, produccion y uso de los mismos.
TW222626B (no) 1991-07-22 1994-04-21 Pfizer
FR2680512B1 (fr) 1991-08-20 1995-01-20 Adir Nouveaux derives de 2,4-thiazolidinedione, leur procede de preparation et les compositions pharmaceutiques qui les contiennent.
EP0601001B1 (en) * 1991-08-26 1997-04-16 PHARMACIA &amp; UPJOHN COMPANY Liquid food product containing 3-guanidinopropionic acid
JPH05271204A (ja) 1992-03-26 1993-10-19 Japan Tobacco Inc 新規なトリアジン誘導体
US5264451A (en) 1992-04-07 1993-11-23 American Home Products Corporation Process for treating hyperglycemia using trifluoromethyl substituted 3H-pyrazol-3-ones
JPH07505647A (ja) 1992-04-10 1995-06-22 スミスクライン・ビーチャム・パブリック・リミテッド・カンパニー 複素環化合物および２型糖尿病の治療におけるそれらの使用
AU4104593A (en) 1992-05-05 1993-11-29 Upjohn Company, The A process for producing pioglitazone metabolite
RU2134686C1 (ru) 1992-07-03 1999-08-20 Смитклайн Бичам П.Л.С. Гетероциклическое соединение, или его таутомерная форма, и/или фармацевтически приемлемая соль, и/или фармацевтически приемлемый сольват, фармацевтическая композиция, снижающая содержание глюкозы в крови, способ лечения и/или профилактики гипергликемии
US5232945A (en) 1992-07-20 1993-08-03 Pfizer Inc. 3-aryl-2-hydroxypropionic acid derivatives and analogs as antihypertensives
GB9218830D0 (en) * 1992-09-05 1992-10-21 Smithkline Beecham Plc Novel compounds
US5478852C1 (en) 1993-09-15 2001-03-13 Sankyo Co Use of thiazolidinedione derivatives and related antihyperglycemic agents in the treatment of impaired glucose tolerance in order to prevent or delay the onset of noninsulin-dependent diabetes mellitus
TW438587B (en) * 1995-06-20 2001-06-07 Takeda Chemical Industries Ltd A pharmaceutical composition for prophylaxis and treatment of diabetes
US5859037A (en) * 1997-02-19 1999-01-12 Warner-Lambert Company Sulfonylurea-glitazone combinations for diabetes

Also Published As

Publication number Publication date
TR199903096T2 (xx) 2000-08-21
TW542717B (en) 2003-07-21
CA2294385A1 (en) 1998-12-23
BG104058A (en) 2000-10-31
EA003025B1 (ru) 2002-12-26
IL133137A0 (en) 2001-03-19
AU8539298A (en) 1999-01-04
CZ299310B6 (cs) 2008-06-18
PL198018B1 (pl) 2008-05-30
IN189319B (no) 2003-02-08
EP0999845B1 (en) 2007-02-14
KR20070011651A (ko) 2007-01-24
OA11510A (en) 2004-02-03
ID24065A (id) 2000-07-06
EP2266576A1 (en) 2010-12-29
CO4940457A1 (es) 2000-07-24
MY125855A (en) 2006-08-30
PL337510A1 (en) 2000-08-28
AR012996A1 (es) 2000-11-22
AP9901717A0 (en) 1999-12-31
AP1600A (en) 2006-04-28
CN1260719A (zh) 2000-07-19
EP1671637A2 (en) 2006-06-21
CZ9904577A3 (en) 2001-05-16
UY25048A1 (es) 2000-09-29
BG109397A (bg) 2006-05-31
EP1671637A3 (en) 2007-12-19
MA24571A1 (fr) 1998-12-31
SK179199A3 (en) 2000-11-07
PE108199A1 (es) 2000-01-14
KR20010013840A (ko) 2001-02-26
IL133137A (en) 2004-02-08
BG64817B1 (bg) 2006-05-31
EP0999845A1 (en) 2000-05-17
NO326263B1 (no) 2008-10-27
DZ2522A1 (fr) 2003-02-01
CN1168451C (zh) 2004-09-29
NZ501163A (en) 2002-02-01
HK1028200A1 (en) 2001-02-09
EA200000039A1 (ru) 2000-08-28
DE69837089D1 (de) 2007-03-29
SK286028B6 (sk) 2008-01-07
UA67743C2 (uk) 2004-07-15
DE69837089T2 (de) 2007-06-21
NO2009002I1 (no) 2009-03-02
ES2283064T3 (es) 2007-10-16
AR008025A1 (es) 1999-12-09
NO996264L (no) 2000-02-17
ATE353654T1 (de) 2007-03-15
CA2294385C (en) 2007-06-05
BR9810142A (pt) 2000-08-08
KR20080011356A (ko) 2008-02-01
NO20083276L (no) 2000-02-17
WO1998057649A1 (en) 1998-12-23
JP2001523270A (ja) 2001-11-20

Similar Documents

Publication Publication Date Title
NO996266L (no) Behandling av diabetes tiazolidindion og metformin
DK1174135T3 (da) Farmaceutisk sammensætning omfattende pioglitazon og glimepirid til anvendelse i behandling af diabetes
EE9900328A (et) Tiasooli benseensulfoonamiidid ß3-agonistidena diabeedi ja rasvumuse ravis
FI970357A (fi) Tyypin II diabeteksen hoitoon käyttökelpoisia bensoksatsoli- ja pyridiinijohdannaisia
NO994613D0 (no) Fremgangsmaate og preparat til behandling av sövn-apne
HUP0003876A3 (en) Use of thiazolidinedione derivatives in the treatment of polycystic ovary syndrome and gestational diabetes
PT1017408E (pt) Utilizacao de tetra-hidrolipstatina no tratamento de diabetes de tipo ii
NO996265L (no) Behandling av diabetes med rosiglitazon og insulin
DK1001783T3 (da) Behandling af diabetes med thiazolidindion, insulinsekretagog og biguanid
NO20000229D0 (no) Behandling av diabetes med tiazolidindion og sulfonylurea
NO996264L (no) Behandling av diabetes med tiazolidindion og sulfonylurea
NO996270D0 (no) Behandling av diabetes med tiazolidindion og &lt;alfa&gt;- glukosidaseinhibitor
IL133907A0 (en) Treatment of diabetes with thiazolidinedione, insulin secretagogue and alpha glucocidase inhibitor
HUP0002668A3 (en) Treatment of diabetes with thiazolidinedione and metformin
HUP0002669A3 (en) Treatment of diabetes with thiazolidinedione and sulphonylurea

Legal Events

Date Code Title Description
SPCF Filing of supplementary protection certificate

Free format text: PRODUCT NAME: AVAGLIM - ROSIGLITAZON/GLIMEPIRID; NAT. REG. NO/DATE: EU106349001-008NO 20060713; FIRST REG. NO/DATE: EU , EU106349001-008 20060627

Spc suppl protection certif: 2009002

Filing date: 20090213

MM1K Lapsed by not paying the annual fees